GLP 1 Agonists News, Articles and Research

GLP 1 agonists Archives NSF News
GLP 1 agonists Archives NSF News

Explore authoritative articles on GLP-1 , semaglutide, peptide therapeutics, weight loss, diabetes, and emerging treatments. This hub delivers evidence-based insights for clinicians, researchers ...

GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1
GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1

Glucagon-like peptide-1 ( GLP-1 ) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...

Oral small

The activity of GLP 1 and GIP for Type 2 Diabetes and Obesity
The activity of GLP 1 and GIP for Type 2 Diabetes and Obesity

In the study, researchers at the University of Virginia specifically investigated small-molecule GLP-1 receptor agonists , such as the Food and Drug Administration (FDA)-approved orforglipron, which can be taken orally and are cheaper to produce than their injectable counterparts.

GLP-1 receptor agonists — sold under brand names like Ozempic and Mounjaro — were initially developed to treat diabetes. But instead of addressing biomarkers linked to certain disease outcomes, these drugs influence the central cardio-kidney metabolic process, Vaduganathan said.

10 Cardiovascular Disease and Risk Management Standards of Care
10 Cardiovascular Disease and Risk Management Standards of Care

Useful Notes on Glp 1 Agonists Archives Nsf News

GLP-1 receptor agonists like semaglutide, liraglutide, dulaglutide and tirzepatide reduce not only fat but also lean muscle mass. This makes physical activity essential for preserving strength and long-term health, according to study lead Sajana Maharjan, M.D., of HSHS St. John's Hospital in Springfield, Ill.

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists , popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health benefits, including reduced risks of addiction, Alzheimer's, and dementia.

Figure 3 from GLP 1 receptor agonists in the treatment of type 2
Figure 3 from GLP 1 receptor agonists in the treatment of type 2

Current Perspectives on GLP

This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor ( GLP -1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding ...

The new treatments are in a class of drugs known as GLP-1 agonists , and this generation of very effective GLP-1 agonists were approved for obesity treatment in the U.S. market in 2021.

Frontiers
Frontiers

The expanding landscape of GLP

This Review discusses the expansion of glucagon-like peptide-1 ( GLP-1 ) medicines beyond type 2 diabetes and obesity, outlining opportunities for new indications, key questions around benefits and ...

SGLT2 Inhibitors vs GLP 1 Agonists to Treat the Heart the Kidneys
SGLT2 Inhibitors vs GLP 1 Agonists to Treat the Heart the Kidneys
Best Glp 1 Receptor Agonists For Type 2 Diabetes In 2026
Best Glp 1 Receptor Agonists For Type 2 Diabetes In 2026
Glp 1 アーモンド 効果 GLP 1とは FIEYNX
Glp 1 アーモンド 効果 GLP 1とは FIEYNX
Understanding GLP 1 Agonists More Than Just Weight Loss Workout
Understanding GLP 1 Agonists More Than Just Weight Loss Workout
Relative effects of glucagon like peptide 1 GLP 1 agonists vs
Relative effects of glucagon like peptide 1 GLP 1 agonists vs
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
Indications for GLP 1 GIP RA Summary Sheet and Beyond Diabetes
Indications for GLP 1 GIP RA Summary Sheet and Beyond Diabetes
From a Glycocentric Approach to Prevention of Multi Organ Damage
From a Glycocentric Approach to Prevention of Multi Organ Damage

A drug already in clinical trials for age-related muscle loss might help GLP-1 users rebuild muscle after damage while losing weight.